National Association of Professional Women honors Monica C. Hernandez as a 2013/2014 Professional Woman of the Year for leadership in pharmaceuticals and biotechnology with this prestigious distinction. An established professional, Ms. Hernandez administers her responsibilities in her role as clinical trial lead with the highest level of proficiency and accountability with a strong commitment to her company’s tireless passion to enhance the health and quality of human life around the world.

A leading force in the pharmaceutical industry, Otsuka Pharmaceutical Development & Commercialization (OPDC) undergoes each strenuous step necessary to create new materials that improve the quality of human health. OPDC is in the process of developing countless compounds to treat disorders in the neuroscience, oncology and cardio-renal therapeutic arenas, while implementing global strategies that will lead to their marketing and registration.

Ever mindful of these efforts, Ms. Hernandez maintains overall accountability for each clinical trial that makes it possible for these compounds to change the lives of clients worldwide. She expertly executes the clinical trial objectives while keeping a strong handle on timeline management, authorship of clinical trial documents, budget management and overall trial oversight in adherence to OPDC’S guidelines and policies.

Ms. Hernandez keeps pace with the exciting challenges that accompany the evolution of the healthcare industry through her affiliation with RAPS. For her determination in improving human health grounded in her most personal standards of excellence, Monica Hernandez is being honored as a role model for professional women in all walks of life.

About NAPW

As the largest, most-recognized organization of women in the country, spanning virtually every industry and profession, the National Association of Professional Women is a powerfully vibrant networking community with over 500,000 members and nearly 400 Local Chapters. Through innovative resources, unique tools and progressive benefits, professional women interact, advance their knowledge, exchange ideas and empower each other.

According to a new market report, “Managed Security Services Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019,” published by Transparency Market Research, the market was valued at USD 9,249.7 million in 2012 and is expected to reach USD 24,127.1 million by 2019 at a CAGR of 15.4% from 2013 – 2019. The market growth is driven by increased demand for applications such as ‘network security’ and ‘confidentiality’ services. Cloud-based managed security service is seen as an emerging market and is expected to drive market growth in the near future.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/managed-security-services-market.html.

Industry verticals such as banking and finance services and insurance (BFSI), government and utilities, and telecom and IT, are seen as key demand drivers during the forecast period. Collectively, these segments accounted for 59.2% of the marker share in 2012. Due to fast growing demand from companies under the BFSI sector, this sector is expected to have highest market share throughout the forecast period. This is largely due to increase in incidences of frauds, payment defaults, and stringent regulations regarding GRC (governance, risk, and compliance). This in turn has pushed companies to adopt specialized solutions from managed security services providers, so as they can ensure the confidentiality and security of customer records and information.

Different applications of managed security services are network security, access control, compliance, confidentiality, and ‘risk and vulnerability management’. Among these applications, network security, confidentiality, and compliance services are emerging as leading segments. These segments accounted for approximately 67.4% of market revenue share in 2012.

Managed security services are currently delivered through CPE (consumer premise equipment) based, cloud based, and hybrid (combination of CPE and cloud) models. Among all, cloud based services delivery model held largest share owing to the various benefits such as ease of installation and maintenance and lower cost. Scope for upgrade as per requirements and ease of switching the vendor are some of the factors supporting demand for cloud based managed security services.

North America is expected to remain largest market for managed security services due to the shift in existing corporate governance policies and compliance requirements for retail, financial services, energy, and healthcare market. Moreover, under current economical scenario, many businesses in North America are relocating in order to expand geographically or to reduce operations cost (as compared to operations in city centers). However, Asia Pacific region with its fast growing BFSI, IT and telecom, and pharmaceutical industry, is forecast to record fastest growth for managed security services, with demand primarily contributed by SMBs (small and medium businesses).

The global managed security services market is driven be growing demand from SMBs (small and medium businesses) and large enterprises too, which are looking for risk transfer and cost reduction on business support activities. Amidst growing preference for e-commerce and digital data generation, businesses are pushed to safeguard their intellectual assets, of which data security is a key concern. Thus, depending on regional regulations and extent of network security, the global market is witnessing varying growth patterns worldwide. These variations exist in terms of applications desired and delivery model preferred. This report is thereby produced to give a detailed overview of the ongoing trends in the market. It includes review of market dynamics with focus on market drivers, growth challenges (restraints), and opportunities. The value chain analysis and Porter’s five forces analysis included in the report further help in assessing the market situation and competitiveness. Market attractiveness analysis highlights key industry segments and their comparative attractiveness against other segments.

Apart from the detailed sub-segment analysis as illustrated below, this report also provides company profiles of the key market players. The competitive profiling of these players includes company and financial overview, business strategies adopted by them, and their recent developments which can help in assessing competition in the market. Some of the major companies included in this report include International Business Machines Corporation (IBM), AT&T Inc., Trustwave Holdings, Inc., Dell SecureWorks, Inc., Fujitsu Ltd., Symantec Corporation, Hewlett-Packard Company (HP), and EMC Corporation, among others.

FANAFI (Find A Need And Fill It), is a people-centered corporation driven by finding human needs worldwide, and filling them as part of its social responsibilities to fellow humans, in the course of doing business.

According to Fanafi President and CEO, Dr. Peter U. Nwangwu, a professor of pharmacology, toxicology, and clinical pharmacy who also served as former President and CEO of a U.S pharmaceutical manufacturing company for 15 years, “the dire and compelling unemployment problems in Nigeria is sad and pathetic. Nearly 60% of young university graduates are unemployed. The government does not have the capacity or will to solve the problem. Therefore corporations and individuals with conscience and goodwill must step into the situation and find creative ways to create jobs in Nigeria by engaging the unemployed and giving them the opportunity to create wealth for themselves through entrepreneurship.”

Fanafi owns the brand and worldwide distribution rights of Splendora, a new feminine super maxi-pad created in the USA. Independent laboratory testing found Splendora’s rate of absorption to be superior by 200% as compared to leading pads in the market

Fanafi’s plan is simple. The first stage is recruiting 200 Nigerian entrepreneurs to become

investor-distributors. Each distributor will employ ten independent sales agents to market directly to end-users. A generous 40% profit margin will be split 50/50 between the investor-distributor, and each sales agent under their supervision. So each sales agent keeps 20% of their total sale, and the investor-distributor keeps 20% of the sales volume of each of the ten sales agents under their supervision.

Fanafi is actively reaching out to Nigerian entrepreneurs and Nigerian job seekers:

1. Investor-distributors need to be pharmacists or non-pharmacists with experience in the healthcare products distribution business or related. They should have the capacity to manage at least ten sales agents and need an operating office or base.

The minimum investment is N90,000 which is required to purchase ten cartons of Splendora to engage the ten sales agents and guide them in sales to end-users.

2. Independent sales agents need to have some education, proper sales and presentation skills, positive attitude and good manners. Fanafi Nigerian job seekers and entrepreneurs will be trained and supervised by the investor-distributors. They do not require capital, because they will be supplied products by the Investor-distributors. The independent sales agents have the opportunity to become independent-distributors over time once they acquire the proper sales and management experience and capital required to purchase products and recruit ten sales agents.

Fanafi is planning to release additional products like “Bouncing Baby”, a unique superior baby diaper in four sizes, and “Dignity”, effective adult incontinence pad, which will both be introduced by end of April 2014 to increase the profit centers for the entrepreneurs. Other beauty products in the health and beauty inventory to be introduced in later months include colognes and jewelry.

Separating membrance is a kind of thin-layer substance with selective penetration function. It is for the use of concentration, separation and purification, and is widely applied in the sectors such as environment, energy, chemical, electronics, pharmaceuticals and food.

In 2012, the global market scale of separating membrance products approached USD12 billion, of which, the market size of reverse osmosis membrance (including nanofiltration membrance), micro-filtration membrance and ultrafiltration membrance stood at around 95%. Worldwide, industrial players from Japan and the United States play a more dominant role, cases including Toray Industries, Mitsubishi Rayon, Asahi Kasei Corporationin all professional in micro-filtration and ultrafilatration membrance fields, as well as Hydranautics, The Dow Chemical Company, and GE in reverse osmosis membrance/nanofiltration membrance arenas.

View Full Report With Complete TOC at http://www.researchmoz.us/global-and-china-separating-membrane-industry-report-2013-2016-report.html

China separating membrane market has witnessed robust development with the growth pace keeping at 20%-30% in last ten years, albeit as a later starter. In 2012, the size of China separating membrance products market approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. it is projected that China separating membrance market will continue its growth rate by around 20% in the upcoming years and that the figure by 2016 will jump to roughly RMB25 billion.

An integrated membrance industrial system has taken shape in China, with major products covering reverse osmosis membrance, micro-filtration membrance and ultrafiltration membrance with the market scale making up around 92%. Other separating membrance products include electric-driven membrance, gas separation membrane, medical membrance, etc.

Reverse osmosis membrance features the widest application, with the domestic market being occupied by foreign companies. And Chinese industrial players represented by Vontron Technology and Hangzhou Water Treatment Technology Development Center hold only 15% market share.

China micro-filtration membrance and ultrafiltration membrance markets demonstrate the fiercest competition, with the market occupancy nationwide exceeding 60%. China has more than 100 micro-filtration membrance and ultrafiltration membrance manufacturers consisting of Beijing Origin Water Technology, MOTIMO, and LITREE. However, foreign counterparts, such as Toray Industries and Asahi Kasei Corporation, are still taking a dominant position in high-end fields such as ultrapure water for electronic industry use, electrophoresis paint recycling, pharmaceutical, and enzymic preparation fields.

Browse Other Published Reports By Research In China – http://www.researchmoz.us/publisher/research-in-china-67.html

Separating membrance is made from organic or inorganic materials. And inorganic materials are mainly ceramic and metal, while organic materials mainly refer to all kinds of chemical raw materials. For example, the reverse osmosis membrance is commonly made from aromatic polyamide, while micro-filtration membrance and ultrafiltration membrance is mainly made from PVDF, polysulfone, PES and PVC, etc. Presently, China has a small number of companies involving in the production of membrance raw materials. Coupled with unstable quality, China imports around 60% membrance raw material resin.

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Expansion of Marijuana Legalization Spurs Movement for Child Safety in Washington and Colorado

Commerce, CA (PRWEB) December 26, 2013

Colorado has seen an increase in cases of pediatric marijuana poisonings (14) and officials are revising regulations on “child safe packaging” that dispensaries are allowed to use in the sale of medical and recreational marijuana. “There are many misconceptions about what really qualifies as child safe packaging” a representative of A&A Packaging says “This is especially true in states like Colorado and Washington where recreational marijuana has been approved.”

Recreational marijuana legislation was a big win for proponents of full legalization, but they are still very much an experiment that the rest of the nation is keeping their eyes on. States that have current medical marijuana laws are no exception. The Colorado poisoning incidents are bringing attention to the fact that medical and recreational marijuana is not only sold in the form of cannabis for the purpose of smoking, but is also sold as baked goods and candy meant for ingestion. Children are many times more likely to confuse these edibles for normal treats and accidentally ingest them.

With no regulations yet in place, some dispensary owners are selling marijuana products in what amounts to little more than zip-lock bags, but some critics point out that these containers do absolutely nothing to promote child safety. “The practice of selling marijuana in baggies is a relic of a bygone era,” says Eric Price, a longtime activist from Seattle who has lobbied for both medical and recreational marijuana legislation. “This calls back to the black market and its only purpose it to package it in a way consistent with customer expectations. You can’t sell Aspirin or Tylenol in baggies, so why would selling marijuana in baggies be acceptable?”

Legislators in Colorado agree with price. The Colorado legislature is putting regulations in place that may soon be a model for the rest of the country: requiring that all marijuana infused products be sold in child resistant packaging. A&A packaging’s representative believes that this is a big step in the maturation of the industry “In order to fully comply with these regulations, it is important for dispensaries to sell their product in opaque child-safe bottles with reversible caps. This will ensure that not only are dispensaries complying with the law but also changing the image of the product to match the legitimacy of established over-the-counter and prescription medications.”

A&A Packaging is California-based business that specializes in medical marijuana packaging and products for both patients and medical marijuana businesses. They offer a variety of packaging mediums from pharmaceutical grade plastic to durable acrylic and glass items designed to keep a patient’s medicine fresh and safe. They are committed to the cause of patients who are suffering from conditions that medical marijuana can help treat, and also strive to treat the medical marijuana industry as a legitimate enterprise on par with the pharmaceutical industry. To learn more about how A&A packaging can help you or your business please call 1(888)315-2453 or visit their site at http://www.vialsondemand.com

For More On Child Safe Packaging in Colorado Please Visit The Denver Post at:

Next Breath, LLC, a Specialty Contract Research Organization (CRO) with expertise in analytical testing of pulmonary, nasal drug, and ophthalmic delivery systems, announced today that the company received its ISO (the International Organization for Standardization) and IEC (the International Electrotechnical Commission) 17025:2005 accreditation from the Perry Johnson Laboratory Accreditation. Compliance with this standard provides a globally accepted basis for laboratory accreditation. The standard specifies the management and technical requirements to be met by testing and calibration laboratories in both the organization and management of quality.

The ISO/IEC 17025:2005 also covers testing and calibration performed using standard methods, non-standard methods, and laboratory-developed methods. This accreditation is another illustration of Next Breath’s commitment to quality and technical expertise, and adherence to the highest standards in quality management systems.

Julie Suman, President, says, “We are very pleased with this accreditation, which confirms Next Breath’s commitment to meeting and exceeding the highest quality standards. We work diligently to maintain regulatory standards and we have once again demonstrated our ability to sustain and continuously improve quality systems within our organization.”

About Perry Johnson Laboratory Accreditation

Perry Johnson Laboratory Accreditation, Inc. (PJLA) is a private organization, offering third-party accreditation services for testing and calibration laboratories. We are absolutely committed to meeting and exceeding the requirements and expectations of our clients in terms of the quality of the services we provide. We are a fully recognized accreditation body by the International Laboratory Accreditation Cooperation (ILAC) and by the Asia Pacific Laboratory Accreditation Cooperation (APLAC) to provide testing and calibration accreditation services

About Next Breath

Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.

About Next Breath

Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.

For more information please visit http://www.nextbreath.net or http://www.aptar.com.

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion, taking into consideration the recent news on Actos lawsuits and potential Actos Recall lawsuit.

A new lawsuit was filed on December 10 by a New Hampshire couple in Louisiana Western District Court alleging that the husband suffered bladder cancer from Actos. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. In the lawsuit, the plaintiff claims that he began taking Actos in 2003 and in 2009, he was diagnosed with bladder cancer.

According to the Judicial Panel on Multidistrict Litigation, on December 16, there were 2,675 cases pending in the Actos Multidistrict Litigation (MDL 2299, US District Court for the Western District of Louisiana).

On September 25, Businessweek published that Takeda allegedly deceived patients and doctors about the risks of Actos, according to the second case that went to trial (Case no. 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland). According to the lawsuit, Takeda should be held liable for the cancer death of a former US Army translator.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in cases of severe complications, allegedly from Actos. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Actos lawsuits. “For that reason”, he continues, “our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On September 19, a Nevada couple filed a lawsuit in Louisiana Western District Court (case no. 6:2013cv02706) alleging that the man suffered bladder cancer from Actos. In the lawsuit, the plaintiff claims that he was prescribed Actos in 2007, and in 2012 he was diagnosed with bladder cancer.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/12/prweb11439169.htm

Chemist Direct warns against excessive binge drinking during the holiday season

Binge Drinking Detrimental to Health

London (PRWEB UK) 25 December 2013

Government figures show 10 million adults in England regularly exceed the recommended daily limits, increasing their risk of serious illnesses such as heart disease, stroke, liver disease and various cancers. NHS guidelines advise no more than two to three units a day for women or three to four units for men – roughly equal to a large glass of wine for women and two pints of beer for men. 2

The British combine Northern European volumes of consumption with frequency resembling that of Southern Europe and this prevalence to drinking more than the weekly guidelines increases by 15 per cent in men and 11 per cent in women. That equates to 80 drinks over the course of the average holiday, or well over 200 units of alcohol.

More than a quarter said they ended up drinking three times more than normal. Men are more likely to binge drink (up to 81 percent of alcohol binges are done by men) than women and men are also more likely to develop alcohol dependence than women. But 70% of the 3,500 adults questioned by the Department of Health said they plan to cut back. 3

Researchers also found that almost 30 per cent of alcohol consumed in 2005 was “unrecorded” alcohol — referring to alcohol not intended for consumption, home-brewed alcohol, and illegally produced alcohol. In some regions, unrecorded alcohol constituted more than half of all alcohol consumed.

“The amount of unrecorded alcohol consumed is a particular problem, as its consumption is not impacted by public health alcohol policies, such as taxation, which can moderate consumption,” said Dr. Jürgen Rehm, a study author and director of CAMH’s Social and Epidemiological Research Department.

However, this definition does not apply to everyone because the tolerance and the speed of drinking in a session varies from person to person. People who are homozygous for the ALDH2 gene are less likely to binge drink due to severe adverse effects which occur even with moderate amounts of alcohol consumption. Binge drinking increases the risk of heart attack. It could cause you to vomit and if you’re sick when very drunk you could breathe in your own vomit and suffocate. 4

As a reaction to the binge drinking epidemic in Britain, several charities have been created to raise awareness of the dangers of binge drinking and promote responsible drinking. Chemist Direct’s Pharmaceutical Superintendent, Omar El-Gohary, has this advice to add:

“When drinking over the holiday’s, try to pace yourself, avoid drinking more than you are used to and avoid drinking so much that you get drunk. This is even more important if you are out in risky or unfamiliar circumstances. You can easily lose control of what you do or say and may make risky decisions, thinking you’re invulnerable”.

“In addition to long term health risks of drinking to excess such as liver cirrhosis, kidney failure, diabetes and reduced fertility, drinking too much alcohol can lead to alcohol poisoning. The signs of alcohol poisoning can include confusion, irregular breathing, vomiting, seizures, low body temperature and unconsciousness. If you suspect someone has alcohol poisoning contact the emergency services and do not leave them alone until help has arrived”.

Rangamites and their partner associates at Hyatt Regency New Brunswick, NJ

Somerset, New Jersey (PRWEB) December 26, 2013

In a lavish reception held at Hyatt Regency New Brunswick, NJ, the top echelons of Rangam Consultants Inc. outlined their strategic sourcing goals for 2014, while thanking the guests for being cooperative in 2013.

Rangam fulfilled 350+ new positions since 2008, thus securing a hefty 162% revenue growth since the great economic downturn. The newly added jobs expanded RCI’s clientele while simultaneously bettering services to its existing clients from IT and non-IT industries such as pharmaceutical, banking, telecom, energy, and automobile.

“We are confident to keep up the good work in 2014,” said KJ Sharma, senior adviser to RCI and its subsidiary WebTeam Corporation. “Earlier this year we felt proud to receive an award from a leading pharmaceutical client and we were also pleased, but not complacent, to be ranked among the top 5000 Fastest Growing Private Companies in America by the Inc. Magazine,” Sharma added, brimming with optimism that RCI’s journey to bigger and better pastures has just begun.

“At Rangam, we help highly qualified candidates find suitable jobs while ensuring our clients achieve their staffing goals by executing their own growth-oriented strategies. This year in particular has been very successful for us because we have consistently staffed quality candidates to reduce recruitment life cycles and cost-to-company for our clients. Acting as a liaison between customers and candidates, we have provided better training to the latter, just to make sure they help the former meet their goals and expectations by efficiently handling time-sensitive, priority projects,” CEO Nish Parikh said.

“Our clients’ success is our success, and by staffing skilled consultants for our clients’ requirements, we strive to serve both parties the best we can,” President Hetal Parikh said, wishing Happy Holidays and a healthy and prosperous New Year to the attendees.

The year 2013 witnessed a serious urgency in CSR activities, as Rangam was able to make a positive difference in the area of special needs education through its subsidiary WebTeam Corporation. Both Nish and Hetal thanked strategic partners from the autism community for their support and guidance, and extended words of gratitude to MSPs, recruiters and client hiring managers for their help in placing quality resources for technical and non-technical projects of the clients. They also thanked accounts managers for working closely with recruiters and customers, in order to develop a successful and lasting relationship.

Temporary staffing in the post-recession United States gives a degree of importance to strategic sourcing and sustainable business development. Success with newly added clients to its portfolio has provided the Somerset-based company significant economic leverage to strengthen its offshore facility, with an aim to have in place green business practices for the future, a close source divulged.

About Rangam Consultants Inc.

Established in 1995, Rangam Consultants Inc. is among the fastest growing temporary staffing organizations in the United States. With a team of over 230 professionals, RCI has been catering to the temporary staffing requirements of an elite pool of Fortune 500 clients from pharmaceutical, telecom, banking, energy and automobile industries. In addition to staffing and recruitment, Rangam also specializes in mobile application development, web development, infrastructure management, technical documentation, network design and implementation, and voice over IP engineering.

WCCT Global, a full service CRO headquartered in Southern California is pleased to announce a new company wide milestone for the quickest completion of a Clinical Study. WCCT Global was able to take a study from final protocol to last subject completion in just two weeks. This accomplishment is testament to the efficiency of the entire WCCT Global study implementation process. The company has made a commitment to be as efficient as possible for all sponsors. The timeline consisted of WCCT Global being awarded the study on December 3rd and received final protocol on December 5th. Screening consisted of 54 subjects were screened from December 12th through December 17th. The study volunteers checked in on December 18th and completed the study on December 19th. The clinical research coordinating staff at WCCT Global is structured in a way where they can implement all aspects of the study to perform in the most efficient way possible.

WCCT Global’s recruitment department played an intricate role in the study’s success by selecting possible volunteers for the study from their fully engaged “opt-in” database. The volunteers were able to quickly be screened and randomized. This process is testament to the patient recruitment process that WCCT Global has been recognized for industry wide. WCCT Global’s Recruitment Manager Sean Lopez stated, “I am proud to announce this great feat with completing this study in the 2 week timeline. It is our goal for every clinical study to offer sponsors the quickest recruitment programs available.” WCCT Global continues to pioneer what is possible from a full service contract research organization.

More About WCCT Global

WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including first-in-human (FIH), as well as specific therapeutic expertise in allergy, asthma, HCV, ophthalmology, oncology, renal, and vaccines.